arginine and enalapril

arginine has been researched along with enalapril in 27 studies

Research

Studies (27)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's10 (37.04)18.2507
2000's13 (48.15)29.6817
2010's4 (14.81)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Hajj-ali, AF; Zimmerman, BG1
Bennett, T; Gardiner, SM; Kemp, PA; Phillips, K1
Jover, B; Mimran, A; Nafrialdi, N1
Benjamin, N; Lyons, D; Webster, J1
Anderson, S; Brenner, BM; Provoost, AP; Rennke, HG; Simons, JL; Troy, JL1
Bassenge, E; Zanzinger, J; Zheng, X1
Jover, B; Mimran, A1
Antunes, E; De Nucci, G; Metze, K; Moreno, H; Pereira Costa, SK; Piovesan Nathan, L; Zatz, R1
Ishidoya, S; Klahr, S; McCracken, R; Morrissey, JJ1
Bernardini, F; Curione, M; Pezza, B; Pezza, E; Pezza, V1
Dukacz, SA; Feng, MG; Kline, RL; Lee, RM; Yang, LF1
Arvat, E; Benso, A; Bobbio, M; Broglio, F; Ghigo, E; Gottero, C; Granata, R; Trevi, G; Vito, LD1
Delles, C; Gekle, M; John, S; Schmieder, RE; Schneider, MP1
Ishibashi, T; Maehara, K; Maruyama, Y; Noji, H; Ohkawara, H; Ohwada, T; Sakamoto, T; Shindo, J; Sugimoto, K; Yaoita, H1
Chang, MS; Chen, JW; Hsu, NW; Lin, SJ; Wu, TC1
Berne, C; Felldin, M; Foss, A; Källen, R; Korsgren, O; Moberg, L; Nilsson, B; Olsson, A; Salmela, K; Tibell, A; Tufveson, G1
deBlois, D; Der Sarkissian, S; Duguay, D; Marchand, EL1
Condorelli, M; de Nigris, F; Ignarro, LJ; Liguori, A; Napoli, C; Pignalosa, O; Sica, V1
Chen, Z; Jiang, JL; Li, YJ; Xu, HY; Zhu, HQ1
Chen, BM; Tao, LJ; Xiong, Y; Zhang, WR1
Block, D; Bökenkamp, A; deJong, M; Ludwig, M; van Hagen, JM; van Wijk, JA1
Amorena, CE; Diaz-Sylvester, PL; Dieguez, SM; Fiori, MC; Lopardo, ML; Müller, AC1
Pronko, TP; Zinchuk, VV1
Cordellini, S; Gaspar, AF1
Abu el Maaty, MA; El-Maraghy, SA; Fahim, AT; Gad, MZ; Hamdy, MA1

Reviews

1 review(s) available for arginine and enalapril

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

8 trial(s) available for arginine and enalapril

ArticleYear
The effect of antihypertensive therapy on responsiveness to local intra-arterial NG-monomethyl-L-arginine in patients with essential hypertension.
    Journal of hypertension, 1994, Volume: 12, Issue:9

    Topics: Amlodipine; Arginine; Blood Pressure; Double-Blind Method; Enalapril; Female; Forearm; Humans; Hypertension; Male; Middle Aged; omega-N-Methylarginine; Regional Blood Flow

1994
Study of supplemental oral l-arginine in hypertensives treated with enalapril + hydrochlorothiazide.
    American journal of hypertension, 1998, Volume: 11, Issue:10

    Topics: Administration, Oral; Antihypertensive Agents; Arginine; Drug Therapy, Combination; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged

1998
Effect of digoxin on the somatotroph responsiveness to growth hormone-releasing hormone (GHRH) alone or combined with arginine in normal young volunteers.
    Clinical endocrinology, 2001, Volume: 55, Issue:6

    Topics: Adult; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arginine; Cardiotonic Agents; Depression, Chemical; Digoxin; Diuretics; Enalapril; Furosemide; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Male; Statistics, Nonparametric

2001
Angiotensin converting enzyme inhibition and angiotensin II AT1-receptor blockade reduce the levels of asymmetrical N(G), N(G)-dimethylarginine in human essential hypertension.
    American journal of hypertension, 2002, Volume: 15, Issue:7 Pt 1

    Topics: Acrylates; Adult; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arginine; Blood Pressure; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Enalapril; Endothelium, Vascular; Humans; Hypertension; Imidazoles; Male; Receptor, Angiotensin, Type 1; Thiophenes

2002
Long-term angiotensin-converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X.
    The American journal of cardiology, 2002, Nov-01, Volume: 90, Issue:9

    Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Arginine; Biological Availability; Coronary Circulation; Double-Blind Method; Enalapril; Endothelium, Vascular; Exercise Test; Female; Hemodynamics; Humans; Male; Microcirculation; Microvascular Angina; Middle Aged; Nitric Oxide; Statistics as Topic; Time; Treatment Outcome; von Willebrand Factor

2002
Sulfhydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension.
    American heart journal, 2004, Volume: 148, Issue:1

    Topics: Angiotensin-Converting Enzyme Inhibitors; Arginine; Captopril; Enalapril; Female; Humans; Hypertension; Lipid Peroxidation; Lipoproteins, LDL; Male; Middle Aged; Nitrates; Nitric Oxide; Nitrites; Oxidative Stress

2004
[Changes of serum asymmetric dimethylarginine in essential hypertension before and after the treatment].
    Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2005, Volume: 30, Issue:1

    Topics: Adult; Aged; Antihypertensive Agents; Arginine; Enalapril; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase

2005
Effect of nebivolol on blood oxygen transport indices and endothelial dysfunction in patients with arterial hypertension.
    Clinical physiology and functional imaging, 2009, Volume: 29, Issue:3

    Topics: Adrenergic beta-Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arginine; Benzopyrans; Drug Therapy, Combination; Enalapril; Endothelium, Vascular; Ethanolamines; Female; Humans; Hypertension; Male; Middle Aged; Nebivolol; Nitric Oxide; Oxygen; Oxyhemoglobins; Severity of Illness Index; Treatment Outcome

2009

Other Studies

18 other study(ies) available for arginine and enalapril

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Nitric oxide participation in renal hemodynamic effect of angiotensin converting enzyme inhibitor lisinopril.
    European journal of pharmacology, 1992, Mar-03, Volume: 212, Issue:2-3

    Topics: Amino Acid Oxidoreductases; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Enalapril; Hemodynamics; Lisinopril; Male; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Rabbits; Renal Circulation

1992
Factors affecting the regional haemodynamic responses to glyceryl trinitrate and molsidomine in conscious rats.
    British journal of pharmacology, 1991, Volume: 104, Issue:1

    Topics: Animals; Arginine; Blood Pressure; Captopril; Enalapril; Heart Rate; Hemodynamics; Hindlimb; Male; Molsidomine; NG-Nitroarginine Methyl Ester; Nitroglycerin; Rats; Regional Blood Flow; Renal Circulation; Renin-Angiotensin System; Splanchnic Circulation; Vasodilation

1991
Endogenous vasoactive systems and the pressor effect of acute N omega-nitro-L-arginine methyl ester administration.
    Journal of cardiovascular pharmacology, 1994, Volume: 23, Issue:5

    Topics: Adrenergic alpha-Antagonists; Angiotensin II; Animals; Arginine; Biphenyl Compounds; Blood Pressure; Desoxycorticosterone; Diet, Sodium-Restricted; Enalapril; Imidazoles; Losartan; Male; NG-Nitroarginine Methyl Ester; Nicardipine; Nitric Oxide; Rats; Rats, Wistar; Renin-Angiotensin System; Tetrazoles; Vasoconstriction

1994
Modulation of glomerular hypertension defines susceptibility to progressive glomerular injury.
    Kidney international, 1994, Volume: 46, Issue:2

    Topics: Animals; Arginine; Blood Pressure; Disease Susceptibility; Enalapril; Glomerulosclerosis, Focal Segmental; Hemodynamics; Hypertension, Renovascular; Kidney Glomerulus; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Mutant Strains; Renal Circulation

1994
Endothelium dependent vasomotor responses to endogenous agonists are potentiated following ACE inhibition by a bradykinin dependent mechanism.
    Cardiovascular research, 1994, Volume: 28, Issue:2

    Topics: Acetylcholine; Adenosine; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Bradykinin; Captopril; Coronary Circulation; Dogs; Drug Synergism; Enalapril; Endothelium, Vascular; Female; Indomethacin; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Regional Blood Flow; Vasodilation

1994
Renin-angiotensin system in the pressor effect of acute N-omega-nitro-L-arginine methyl ester.
    Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1993, Volume: 11, Issue:5

    Topics: Animals; Arginine; Biphenyl Compounds; Blood Pressure; Desoxycorticosterone; Enalapril; Heart Rate; Imidazoles; Losartan; Male; Nephrectomy; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar; Renin-Angiotensin System; Tetrazoles

1993
Enalapril does not prevent the myocardial ischemia caused by the chronic inhibition of nitric oxide synthesis.
    European journal of pharmacology, 1995, Dec-04, Volume: 287, Issue:1

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arginine; Enalapril; Heart; Male; Myocardial Ischemia; NG-Nitroarginine Methyl Ester; Nitric Oxide; Organ Size; Rats; Rats, Wistar

1995
Nitric oxide generation ameliorates the tubulointerstitial fibrosis of obstructive nephropathy.
    Journal of the American Society of Nephrology : JASN, 1996, Volume: 7, Issue:10

    Topics: Actins; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Collagen; Enalapril; Enzyme Inhibitors; Female; Fibrosis; Kidney; Kidney Diseases; Kidney Tubules; Muscle, Smooth; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Ureteral Obstruction

1996
Abnormal renal medullary response to angiotensin II in SHR is corrected by long-term enalapril treatment.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2001, Volume: 280, Issue:4

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Arterioles; Blood Pressure; Enalapril; Endothelium, Vascular; Kidney Medulla; Laser-Doppler Flowmetry; Male; Muscle Relaxation; NG-Nitroarginine Methyl Ester; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Regional Blood Flow; Renal Artery

2001
Different contribution of apoptosis to the antiproliferative effects of L-arginine, enalapril and losartan on neointimal growth inhibition after balloon arterial injury.
    Circulation journal : official journal of the Japanese Circulation Society, 2002, Volume: 66, Issue:10

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Arginine; Carotid Artery Injuries; Catheterization; Cell Division; Enalapril; Graft Occlusion, Vascular; Losartan; Male; Muscle, Smooth, Vascular; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rats; Rats, Sprague-Dawley; Up-Regulation

2002
Nicotinamide inhibits tissue factor expression in isolated human pancreatic islets: implications for clinical islet transplantation.
    Transplantation, 2003, Nov-15, Volume: 76, Issue:9

    Topics: Arginine; Cells, Cultured; Chemokine CCL2; Cyclosporine; Enalapril; Gene Expression Regulation; Humans; Islets of Langerhans; Islets of Langerhans Transplantation; Kinetics; Niacinamide; Thromboplastin

2003
Synergistic interaction between enalapril, L-arginine and tetrahydrobiopterin in smooth muscle cell apoptosis and aortic remodeling induction in SHR.
    British journal of pharmacology, 2004, Volume: 142, Issue:5

    Topics: Acetylcholine; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Apoptosis; Arginine; Biopterins; Blood Pressure; Body Weight; DNA Fragmentation; Drug Synergism; Enalapril; Endothelium, Vascular; In Situ Nick-End Labeling; Male; Muscle, Smooth, Vascular; Nitric Oxide; Rats; Rats, Inbred SHR; Reactive Oxygen Species; Vasodilator Agents

2004
Angiotensin-converting enzyme inhibitors prevent LDL-induced endothelial dysfunction by reduction of asymmetric dimethylarginine level.
    International journal of cardiology, 2005, May-11, Volume: 101, Issue:1

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Captopril; Cholesterol, LDL; Enalapril; Endothelium, Vascular; Models, Animal; Rats

2005
R561C missense mutation in the SMARCAL1 gene associated with mild Schimke immuno-osseous dysplasia.
    Pediatric nephrology (Berlin, Germany), 2005, Volume: 20, Issue:12

    Topics: Amino Acid Motifs; Amino Acid Sequence; Amino Acid Substitution; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Arginine; Base Sequence; Biopsy; Child; Consanguinity; DNA Helicases; DNA Mutational Analysis; Enalapril; Exons; Follow-Up Studies; Genes, Recessive; Genetic Linkage; Homozygote; Humans; Kidney; Losartan; Male; Molecular Sequence Data; Mutation, Missense; Nephrotic Syndrome; Osteochondrodysplasias; Pedigree; Protein Structure, Tertiary; Radiography; Sequence Homology, Amino Acid; Time Factors; Treatment Outcome; Turkey

2005
Effect of chronic inhibition of converting enzyme on proximal tubule acidification.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2008, Volume: 294, Issue:6

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Citrulline; Enalapril; Kidney Tubules, Proximal; Male; Nitric Oxide; Oxidation-Reduction; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Sodium-Hydrogen Exchanger 3; Sodium-Hydrogen Exchangers; Vacuolar Proton-Translocating ATPases

2008
Combination therapy for the cardiovascular effects of perinatal lead exposure in young and adult rats.
    Arquivos brasileiros de cardiologia, 2014, Volume: 103, Issue:3

    Topics: Age Factors; Animals; Antihypertensive Agents; Arginine; Blood Pressure; Body Weight; Cardiovascular System; Chelating Agents; Combined Modality Therapy; Enalapril; Female; Hypertension; Lactation; Lead; Lead Poisoning; Male; Pregnancy; Prenatal Exposure Delayed Effects; Rats, Wistar; Succimer; Time Factors; Treatment Outcome

2014
Investigating the cardio-protective abilities of supplemental L-arginine on parameters of endothelial function in a hypercholesterolemic animal model.
    Journal of nutritional science and vitaminology, 2014, Volume: 60, Issue:3

    Topics: Amidohydrolases; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Cardiotonic Agents; Cardiovascular Diseases; Dietary Supplements; Disease Models, Animal; Enalapril; Endothelium, Vascular; Heart; Hypercholesterolemia; Male; Malondialdehyde; Nitric Oxide; Nitroglycerin; Oxidative Stress; Rabbits

2014